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In previous studies, we reported statistically
significant associations between ambient air
pollution and cardiac arrhythmias in patients
with implantable cardioverter defibrillator
(ICD) devices (Dockery et al. 2005a, 2005b;
Peters et al. 2000b; Rich et al. 2005). A pilot
study of 100 patients in Boston, Massachusetts,
found signiﬁcantly increased risk of ICD dis-
charges associated with nitrogen dioxide and
black carbon among patients with repeated
events (Peters et al. 2000b). In a larger study of
approximately 200 Boston-area ICD patients,
we found a nonstatistically significant
increased risk of ventricular arrhythmias (con-
firmed by an electrophysiologist) associated
with 2-day mean NO2, particulate matter
< 2.5 µm in aerodynamic diameter (PM2.5),
black carbon, carbon monoxide, ozone, and
sulfur dioxide (Dockery et al. 2005a, 2005b).
In a case–crossover analysis of these data,
which allowed us to match the time of onset of
these arrhythmias with ambient air pollution
concentrations, we found stronger, statistically
signiﬁcant associations of ventricular arrhyth-
mias with mean PM2.5 and O3 in the 24 hr
before the arrhythmia (Rich et al. 2005).
Although ICDs are designed to detect and
treat life-threatening ventricular arrhythmias,
supraventricular arrhythmias may also be
detected. Many of these supraventricular
arrhythmias may be atrial ﬁbrillation, which is
the most common sustained arrhythmia in
clinical practice (Go et al. 2001) and a risk
factor for stroke (Prystowsky et al. 1996) and
premature mortality (Kanel et al. 1983). We
used a case–crossover design to examine the
association of ICD-detected paroxysmal atrial
ﬁbrillation and hourly measurements of com-
munity air pollution concentrations.
Materials and Methods
Study population. Two hundred three
patients who had a third-generation Guidant
ICD (Cardiac Pacemakers, Inc., Minneapolis,
MN) implanted at the Tufts–New England
Medical Center between 1 June 1995 and 31
December 1999, were followed until their last
clinic visit before 15 July 2002. Patients who
lived within 40 km (25 mi) of the air pollu-
tion monitoring station at the Harvard School
of Public Health were included for analysis.
The Guidant ICDs record intracardiac elec-
trograms and were the most common ICD
implanted at Tufts–New England Medical
Center during the study period. Each patient’s
ﬁrst 14 days after implantation and any events
that occurred during inpatient hospital visits
were excluded. Further description of this
population has been published previously
(Dockery et al. 2005a, 2005b).
Outcome and clinical data. For each
ICD-recorded episode of tachyarrhythmia, the
date, time, beat-to-beat intervals, and intracar-
diac electrogram before, during, and after
episodes were recovered from the ICD. In a
small number of cases in which the patient
experienced a large number of ICD-detected
episodes since the previous clinic visit, early
electrograms in the ICD memory, but none of
the other episode-speciﬁc data, may have been
overwritten. ICD settings including ventricu-
lar tachycardia rate cutoffs (i.e., detection
rates) were also abstracted from the ICD
records. Ventricular tachycardia rate cutoffs
were set by the treating electrophysiologist
based on the clinical features of the patients.
All of the ICD-detected episodes were
reviewed and characterized by an electrophysi-
ologist (M.S.L) blinded to air pollution levels.
Details of this arrhythmia classiﬁcation have
been published previously (Dockery et al.
2005b). Brieﬂy, patients who presented with
atrial ﬁbrillation at all clinic follow-ups were
classified as in permanent atrial fibrillation,
and they were excluded from this analysis.
Episodes of paroxysmal atrial ﬁbrillation (PAF)
were deﬁned by a ventricular rate between 120
and 200 beats per minute, irregularity of the
beat-to-beat intervals, no change in QRS mor-
phology (except for a small number of cases
with no ventricular electrogram), and lack of
conversion following ventricular therapies
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OBJECTIVES: We reported previously that 24-hr moving average ambient air pollution concen-
trations were positively associated with ventricular arrhythmias detected by implantable
cardioverter defibrillators (ICDs). ICDs also detect paroxysmal atrial fibrillation episodes (PAF)
that result in rapid ventricular rates. In this same cohort of ICD patients, we assessed the associa-
tion between ambient air pollution and episodes of PAF. 
DESIGN: We performed a case–crossover study. 
PARTICIPANTS: Patients who lived in the Boston, Massachusetts, metropolitan area and who had
ICDs implanted between June 1995 and December 1999 (n = 203) were followed until July 2002.
EVALUATIONS/MEASUREMENTS: We used conditional logistic regression to explore the association
between community air pollution and 91 electrophysiologist-confirmed episodes of PAF among
29 subjects.
RESULTS: We found a statistically significant positive association between episodes of PAF and
increased ozone concentration (22 ppb) in the hour before the arrhythmia (odds ratio = 2.08;
95% conﬁdence interval = 1.22, 3.54; p = 0.001). The risk estimate for a longer (24-hr) moving
average was smaller, thus suggesting an immediate effect. Positive but not statistically signiﬁcant
risks were associated with ﬁne particles, nitrogen dioxide, and black carbon.
CONCLUSIONS: Increased ambient O3 pollution was associated with increased risk of episodes of
rapid ventricular response due to PAF, thereby suggesting that community air pollution may be a
precipitant of these events.
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[Online 20 September 2005](except when therapy was not applied). If a
dual-chamber device had been implanted and
an atrial electrogram was available, the atrial
electrogram was also used to characterize ICD-
recorded episodes. This analysis was restricted
to PAF episodes that occurred at least 60 min
after the previous event. Residence ZIP code,
date of birth, race/ethnicity, clinic visit dates,
and medications prescribed (beta-blockers,
digoxin, and other antiarrhythmics) were
abstracted from patients’ records.
The Harvard School of Public Health
Human Subjects Committee and the Tufts–
New England Medical Center Institutional
Review Board approved this record review
study.
Air pollution. The air pollution measure-
ments have been described previously
(Dockery et al. 2005a, 2005b; Rich et al.
2005). Briefly, ambient concentrations of
O3,N O 2, SO2, and CO were measured
hourly by the Massachusetts Department of
Environmental Protection at four to six sites
in the Boston metropolitan area during the
entire follow-up period. We calculated the
hourly average air pollution concentration
across all available monitoring stations,
accounting for differences in the annual mean
and daily standardized deviations of each
monitor (Schwartz 2000). PM2.5 was mea-
sured hourly in South Boston (~ 5 km east of
the Harvard School of Public Health) from
1 April 1995 to 20 January 1998, and at the
Harvard School of Public Health from
16 March 1999 to 31 July 2002. Black car-
bon was measured hourly in South Boston
from 1 April 1995 to 29 March 1997, and at
the Harvard School of Public Health from
15 October 1999 to 31 July 2002.
Acute effect of pollutants. We analyzed the
association of ambient air pollution concentra-
tions and episodes of PAF using a case–
crossover design (Maclure 1991). These meth-
ods have been used previously to study triggers
of acute cardiovascular events (Albert et al.
2000; D’Ippoliti et al. 2003; Hallqvist et al.
2000; Mittleman et al. 1995; Peters et al.
2000a; Rich et al. 2005). In this design, each
subject contributes information as a case dur-
ing the event periods and as a matched control
during nonevent times. Because cases and
their matched controls are derived from the
same person and a conditional analysis is con-
ducted, non-time-varying potential con-
founders such as underlying medical condition
and long-term smoking history are controlled
by design. Variables that may be related to
both air pollution and the occurrence of PAF
that fluctuate over time (e.g., meteorologic
conditions) are possible confounders.
We deﬁned case periods by the detection
time of each confirmed episode of PAF,
rounded to the nearest hour. We matched con-
trol periods on weekday and hour of the day
within the same calendar month (Lumley and
Levy 2000). We calculated average pollution
concentrations and weather conditions during
the hour and during the 24 hours before the
case and control time periods for this analysis.
Conditional logistic regression models,
including the mean pollutant concentration
in the hour of the arrhythmia (lag hour 0)
and natural splines [3 degrees of freedom (df)]
for the mean temperature, dew point, and
barometric pressure in the 24 hr before the
arrhythmia, were run separately for each pol-
lutant (PM2.5, black carbon, NO2, CO, SO2
and O3). Different individuals may have dif-
ferent cardiac responses to pollution, based on
their clinical history and genetic characteris-
tics. Therefore, we included a frailty term
(Therneau and Grambsch 2000) for each sub-
ject (akin to a random intercept) in all the
above models. Odds ratios (ORs), 95% conﬁ-
dence intervals (CIs), and p-values for statis-
tical significance testing are presented for an
interquartile range increase in each pollutant.
We considered associations with longer expo-
sures before the PAF episode using the mean
of the pollutant in the previous 24 hr (lag
hours 0–23).
To assess the sensitivity of our results to
the influence of outliers, we reran analyses,
trimming the highest 5% and lowest 5% of
air pollution concentrations. For O3, which
has a strong seasonal pattern, we examined
whether the association between PAF and O3
concentration was limited to the 6 months
with the highest mean ambient temperature
(May–October) by adding an O3/warm
month interaction term to the conditional
logistic regression model. We assessed the lin-
earity of the PAF and O3 association by
replacing the linear air pollution term with a
penalized spline (3 df) in the conditional
logistic regression model. We plotted the
covariate adjusted log OR for the risk of PAF
in the spline and linear models versus 1-hr O3
concentration.
We used SAS (version 9.1; SAS Institute
Inc., Cary, NC) software to construct all
datasets and to calculate descriptive statistics.
We used S-Plus 6.2 (Insightful Inc., Seattle,
WA) software for all modeling.
Results
There were 203 ICD patients enrolled in the
study who lived within 40 km of the Harvard
School of Public Health with a mean (± SD)
follow-up time of 3.1 ± 1.8 years (maximum =
7.0 years). Ninety-ﬁve patients had a total of
1,574 recorded ICD events, 933 of which
were separated by > 1 hr. Ninety-one (9.8 %)
of these events, among 29 subjects, were con-
firmed episodes of PAF. Because PM2.5 and
black carbon were not measured during the
entire study period, analyses of PM2.5 included
at most 52 episodes of PAF from 22 subjects,
and analyses of black carbon included at most
46 episodes of PAF from 18 subjects.
The 29 subjects with PAF episodes were
primarily male (79%) and white (79%), and
they ranged in age from 45 to 78 years (mean,
65 years). At their ﬁrst clinic follow-up visit,
69% of subjects were listed as being prescribed
beta-blockers, 57% digoxin, and 24% other
antiarrhythmics (i.e., amiodarone, quinidine,
sotalol, or mexilitine). Two subjects (7%) were
not prescribed any of these medications. The
most common diagnoses at implantation were
coronary artery disease (76%) and idiopathic
cardiomyopathy (22%). Before ICD implanta-
tion, 55% of subjects had left ventricular ejec-
tion fractions < 35%. Subjects’ ICDs were
programmed with ventricular tachycardia
detection rates (i.e., ventricular rate threshold
above which the electrogram and date/time for
a tachyarrhythmia would be recorded) that had
a 10th to 90th percentile range of 140 to 200
beats/min (median = 175).
Of the 29 subjects who experienced at
least one episode of PAF, 15 (52%) experi-
enced > 1 event, while 2 (7%) experienced
≥ 10. Twenty (69%) also experienced a ven-
tricular arrhythmia during follow-up. Episodes
of PAF were more frequent in the late morn-
ing (0900–1100 hr), with a smaller evening
peak (1800–2000 hr).
The distributions of air pollution concen-
trations and meteorologic characteristics in
Boston during the study period, averaged
hourly and daily, are summarized in Table 1.
The highest average PM2.5 and black carbon
concentrations were observed early in the
morning (0600–0800 hr), highest NO2 in the
early morning (0600–0800 hr) and early
evening (1600–2100 hr), and highest O3 at
midday (1200–1400 hr). Further detail has
been provided previously (Dockery et al.
2005b).
We found a statistically significant
increased risk of PAF associated with mean O3
concentration in the concurrent hour (lag
hour 0; Table 2). The estimated relative odds
for the 24-hr moving average concentration
was positive (OR > 1), but not statistically sig-
nificant. We did not find statistically signi-
ﬁcant associations with any other pollutant in
the concurrent hour, but associations were
positive for PM2.5 and NO2. Risk estimates
for 24-hr average PM2.5, NO2, and black car-
bon were positive, but none was statistically
significant. Risk estimates for 24-hr average
CO and SO2 were protective (OR < 1), but
neither was statistically signiﬁcant (Table 2).
For O3 in the concurrent hour, there was
little change in risk of PAF when we excluded
the top 5% and bottom 5% of concentrations
(OR = 2.15, 95% CI = 1.04–4.44, p = 0.04).
The association between PAF and O3 in the
concurrent hour in the cold months (OR =
2.21; 95% CI = 0.98–4.98; p = 0.06) was
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1.98; 95% CI = 1.05–3.73; p = 0.04), with no
signiﬁcant interaction (p = 0.84).
Figure 1 shows the covariate adjusted log
OR for the risk of PAF versus 1-hr O3 con-
centration modeled using first a linear term
and then a penalized spline (3 df). We found
no evidence of a deviation from linearity (non-
linear term, p = 0.63).
Discussion
In a study designed to assess the association of
ambient air pollution with ventricular
arrhythmias among ICD patients, 91 of the
ICD-detected episodes were identified by
electrophysiologist review as PAF. Although
these episodes of PAF were likely an 
underrepresentation of all those PAF episodes
experienced by these patients, they provided a
unique opportunity to assess associations
between air pollution and episodes of PAF. We
found a statistically signiﬁcant 2-fold increase
in risk of PAF episodes associated with each
22-ppb increase in mean ambient O3 concen-
tration in the concurrent hour. We found no
evidence that this association was nonlinear.
An earlier study reported a 10.5% increase
in supraventricular ectopy (~ 3.5 beats/hr
increase in supraventricular ectopy compared
to the population mean rate of supraven-
tricular ectopy) associated with each 7-µg/m3
increase in ambient PM10 (particulate matter
< 10 µm in aerodynamic diameter) concent-
ration in a panel of chronic obstructive pul-
monary disease patients (Brauer et al. 2001).
They reported smaller increases in supraven-
tricular ectopy associated with outdoor and
personal PM2.5 and sulfates.
Our ﬁndings identify ambient air pollution
as a potential precipitant of supraventricular
arrhythmias. Atrial ﬁbrillation is the most com-
mon supraventricular arrhythmia. At least 2.3
million adults in the United States have some
form of atrial ﬁbrillation (Go et al. 2001), and
this number is likely an underestimate because
many people with this condition are asympto-
matic (Chugh et al. 2001). The incidence of
atrial ﬁbrillation doubles with each decade of
adult life (Falk 2001). Although atrial fibril-
lation is not usually considered a lethal rhythm,
it is associated with premature mortality and
increased risk for hospitalization and stroke
(Wolf et al. 1998; Benjamin et al. 1998). If not
on antithrombotic therapy, people with atrial
fibrillation have a 5-fold increased risk of
stroke (Ryder and Benjamin 1999). Therefore,
even a modest risk of atrial ﬁbrillation associ-
ated with acute exposure to elevated ambient
air pollution in the general population would
have a substantial attributable risk.
In prior analyses in this cohort of ICD
patients, we found signiﬁcantly increased risk
of ventricular arrhythmias associated with
mean PM2.5 and O3 concentrations in the
24 hr before the episode (Rich et al. 2005),
and marginally significant increased risk
(p < 0.10) associated with mean black carbon
and NO2 concentrations over the previous
2 days (Dockery et al. 2005a, 2005b). The
findings of positive associations between
episodes of PAF and O3 concentration (1-hr) is
consistent with these observations, although
the timing (1 hr vs. 24 hr or 1 day) suggests a
more rapid response to air pollution with PAF.
O3 is an acute lung irritant that has been
associated with acute myocardial infarction
(Ruidavets et al. 2005), decreased lung func-
tion, exacerbation of asthma or other respira-
tory conditions, increased hospitalizations,
and premature mortality (Thurston and Ito
1999). O3 is a highly reactive oxidant formed
Rich et al.
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Table 1. Boston air pollution proﬁle, August 1995 to June 2002. 
Percentile
Parameter No. of hours or days 25th 50th 75th Maximum
PM2.5 (µg/m3)a
Hourly 48,592 5.6 9.2 15.0 84.1
Daily 2079 6.7 9.8 14.5 53.2
Black carbon (µg/m3)b
Hourly 36,789 0.44 0.77 1.35 23.93
Daily 1555 0.58 0.94 1.41 7.32
NO2 (ppb)
Hourly 60,555 15.8 21.7 29.0 78.8
Daily 2526 18.1 22.4 27.3 61.8
SO2 (ppb)
Hourly 60,620 2.6 4.3 7.5 71.6
Daily 2526 3.2 4.8 7.3 31.4
CO (ppm)
Hourly 60,091 0.46 0.73 1.04 5.83
Daily 2526 0.52 0.78 1.03 2.48
O3 (ppb)
Hourly 60,210 11.3 22.2 33.0 119.5
Daily 2524 15.2 22.6 30.9 77.5
Temperature (°C)
Hourly 60,449 3 11 18 36
Daily 2526 4 11 18 32
Dew point (°C)
Hourly 60,356 –3 6 13 25
Daily 2526 –2 5 13 23
Barometric pressure (mmHg)
Hourly 60,379 758 762 766 784
Daily 2525 758 762 766 781
Air pollution was measured hourly; total possible hours = 60,624; total possible days = 2,526.
aConcentrations missing from 21 January 1998 to 15 March 1999. bConcentrations missing from 30 March 1997 to 15
October 1999.
Table 2. ORs for PAF associated with an interquartile range increase in the mean of pollutant lag hours.
No. of No. of PAF
Mean of pollutant Interquartile range Lags subjects episodes OR (95% CI) p-Value
PM2.5 (µg/m3) 9.4 0 22 52 1.41 (0.82–2.42) 0.22
7.8 0–23 22 47 1.13 (0.63–2.03) 0.68
Black carbon (µg/m3) 0.91 0 18 46 0.81 (0.42–1.56) 0.53
0.83 0–23 18 46 1.46 (0.67–3.17) 0.34
NO2 (ppb) 13.2 0 28 90 1.21 (0.80–1.83) 0.37
9.2 0–23 27 89 1.18 (0.79–1.76) 0.43
CO (ppm) 0.58 0 28 90 0.87 (0.56–1.37) 0.55
0.51 0–23 28 90 0.71 (0.39–1.28) 0.25
SO2 (ppb) 4.9 0 28 90 1.02 (0.81–1.28) 0.87
4.1 0–23 28 90 0.99 (0.71–1.39) 0.97
O3 (ppb) 21.7 0 28 90 2.08 (1.22–3.54) 0.007
15.8 0–23 28 89 1.60 (0.89–2.89) 0.12
Figure 1. Log OR of PAF by 1-hr O3 concentration
modeled as a linear term and using a penalized
spline with 3 df. Vertical lines on abscissa indicate
the O3concentrations of observed events.
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by photochemical reactions in the atmosphere.
O3 concentrations are highest on warm sunny
days, and highest during the afternoon hours.
However, we found a statistically significant
association with O3 after adjustment for tem-
perature, and we found no evidence that the
O3 associations were restricted to the six
warmest months.
We also found positive associations with
PM2.5, NO2, and black carbon, but the CIs
were wide and the risk estimates were not sta-
tistically significant. The number of PAF
episodes with matching O3 and NO2 concen-
trations was small (n = 90), and they were
even smaller for PM2.5 (n = 52) and black car-
bon (n = 46), which resulted in reduced power
to detect any associations. Thus, this small
number of confirmed PAF episodes dictates
caution in our interpretation of speciﬁc associ-
ations. Although we have highlighted the asso-
ciation with O3 in the concurrent hour, it
would be premature to attribute the increased
risk of PAF to O3 alone. We suggest that com-
munity air pollution may be associated with
the incidence of PAF. Confirmation of this
association and examination of associations
with speciﬁc pollutants requires a larger num-
ber of conﬁrmed PAF episodes.
A problem in studying incidence of PAF is
the deﬁnition of time of onset of new episodes.
Although the ICD device provides a detection
time for each episode of PAF, this is the time
that the ventricular rate (responding to the
atrial stimulus) exceeded the patient’s speciﬁc
programmed criteria for a tachyarrhythmia.
The PAF episode may have started earlier than
the time recorded by the ICD. This situation
would lead to mismatching of air pollution
concentrations to case and control time peri-
ods. However, this exposure misclassiﬁcation
would be nondifferential with respect to
case/control status. Therefore, it would have
resulted in a bias toward the null, under-
estimates of risk, and wide CIs.
Episodes of PAF also may have been mis-
classiﬁed. However, any outcome misclassiﬁ-
cation, if present, was likely independent of
air pollution levels and nondifferential. This
misclassiﬁcation would have produced wider
CIs, a bias toward the null, and under-
estimates of risk.
Our analysis was limited to a subset of all
PAF episodes that these subjects experienced.
PAF episodes with ventricular response rates
that remained below the ICD’s preset detec-
tion criteria for the duration of the arrhythmia
would not have been recorded. These under-
detected episodes likely represented a substan-
tial fraction of the PAF episodes experienced
by these patients. However, we used the
case–crossover method, where each person
serves as his or her own control, and event
times are contrasted with matched control
times. Such misclassification would have
resulted in a loss of power, but no bias in our
risk estimates. Whether our ﬁnding of an asso-
ciation between transient ambient air pollu-
tion concentrations and PAF is limited to this
particular subset of PAF episodes, however, is
unknown. New studies using devices pro-
grammed to detect a wider range of PAF
episodes with more precise data on the timing
of arrhythmia initiation are required to con-
ﬁrm and quantify this association further.
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